Publications by authors named "Jama Darling"

Claim this Profile
O
Outcomes of early vs late treatment initiation in solid organ transplantation from hepatitis C virus nucleic acid test-positive donors to hepatitis C virus-uninfected recipients: Results from the HCV-TARGET study.
Wesam Aleyadeh, Elizabeth C Verna, Hany Elbeshbeshy, Mark S Sulkowski, Coleman Smith, Jama Darling

Am J Transplant· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inpatient Hepatitis C Treatment Coordination and Initiation for Patients Who Inject Drugs.
L Madeline McCrary, Kate E Roberts, Mary Catherine Bowman, Briana Castillo, Jama M Darling

J Gen Intern Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Pragmatic, Randomized Controlled Trial of Oral Antivirals for the Treatment of Chronic Hepatitis C: The PRIORITIZE Study.
Mark S Sulkowski, Juhi S Moon, Kenneth E Sherman, Giuseppe Morelli, Jama M Darling

Hepatology· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Killing Two Birds With No Stone.
Jane Giang, Dawn S Harrison, Benjamin K Hansen, Michael W Fried, Jama M Darling

Clin Liver Dis (Hoboken)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia.
Marie E Faughnan, Johannes J Mager, Steven W Hetts, Valerie A Palda, Kelly Lang-Robertson, Jama Darling

Ann Intern Med· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Quality Improvement Initiative Results in Improved Rates of Timely Postvariceal Bleeding Surveillance Endoscopy.
Andrew M Moon, Hannah P Kim, A Sidney Barritt, Jama Darling, Shifali Arora

Am J Gastroenterol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Interaction Between Glecaprevir, Pibrentasvir, and Colchicine Causing Rhabdomyolysis in a Patient With Chronic Renal Disease.
Dawn S Harrison, Jane Giang, Jama M Darling

Clin Liver Dis (Hoboken)· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Status of Hepatocellular Carcinoma Does Not Influence Rates of Sustained Virologic Response: An HCV-TARGET Analysis.
Kavita Radhakrishnan, Adrian M Di Bisceglie, K Rajender Reddy, Joseph K Lim, Josh Levitsky, Jama M Darling

Hepatol Commun· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daclatasvir and sofosbuvir treatment of decompensated liver disease or post-liver transplant hepatitis C virus recurrence in patients with advanced liver disease/cirrhosis in a real-world cohort.
Paul Kwo, Michael W Fried, K Rajender Reddy, Consuelo Soldevila-Pico, Saro Khemichian, Jama Darling

Hepatol Commun· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: results of the real-world, clinical practice HCV-TARGET study.
Tania M Welzel, David R Nelson, Giuseppe Morelli, Adrian Di Bisceglie, Rajender K Reddy, Jama Darling

Gut· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mixed Cryoglobulin-induced Esophageal Necrosis in a Patient With Hepatitis C.
Maureen Kimani, Jama M Darling, Alfred Sidney Barritt

J Clin Gastroenterol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High MIG (CXCL9) plasma levels favours response to peginterferon and ribavirin in HCV-infected patients regardless of DPP4 activity.
Susanne Johansson, Willem Talloen, Marianne Tuefferd, Jama Darling, Gregory Fanning

Liver Int· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of Simeprevir Plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients With HCV Genotype 1 Infection.
Mark S Sulkowski, Hugo E Vargas, Adrian M Di Bisceglie, Alexander Kuo, K Rajender Reddy, Jama M Darling

Gastroenterology· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Membranoproliferative glomerulonephritis, type II cryoglobulinemia and triple therapy for hepatitis C: a case series and review of the literature.
Kevin Humphries, Jama M Darling, A Sidney Barritt

Dig Dis Sci· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial.
Eric Lawitz, Jay P Lalezari, Tarek Hassanein, Kris V Kowdley, Fred F Poordad, Jama M Darling

Lancet Infect Dis· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New and Evolving Management Paradigms for Hepatitis C after Liver Transplantation.
A Sidney Barritt, Jama M Darling, Paul H Hayashi

Curr Hepat Rep· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chest pain and progressive shortness of breath in a 60-year-old woman following liver transplantation.
Jennifer S Nelson, Autumn L Jackson, Jama M Darling, David A Gerber

Chest· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitation of pretreatment serum interferon-γ-inducible protein-10 improves the predictive value of an IL28B gene polymorphism for hepatitis C treatment response.
Jama M Darling, Jeroen Aerssens, Gregory Fanning, John G McHutchison, David B Goldstein

Hepatology· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overlap syndrome of autoimmune chronic liver diseases: MRI findings.
W Brian Hyslop, Andrea S Kierans, Polytimi Leonardou, Karen Fritchie, Jama Darling

J Magn Reson Imaging· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nitazoxanide: beyond parasites toward a novel agent for hepatitis C.
Jama M Darling, Michael W Fried

Gastroenterology· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing treatment regimens in hepatitis C.
Jama M Darling, Michael W Fried

Clin Liver Dis· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management and treatment of hepatitis C viral infection: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center program and the National Hepatitis C Program office.

Am J Gastroenterol· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune responses in hepatitis C: is virus or host the problem?
Jama M Darling, Teresa L Wright

Curr Opin Infect Dis· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Keratin 8 and 18 mutations are risk factors for developing liver disease of multiple etiologies.
Nam-On Ku, Jama M Darling, Sheri M Krams, Carlos O Esquivel, Emmet B Keeffe

Proc Natl Acad Sci U S A· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A blood-borne antigen induces rapid T-B cell contact: a potential mechanism for tolerance induction.
Ines Gütgemann, Jama M Darling, Harry B Greenberg, Mark M Davis, Yueh-Hsiu Chien

Immunology· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis